Nasdaq:US$15.41 (+0.36) | HKEX:HK$23.55 (+0.00) | AIM:£2.23 (-0.04)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 18 Jun 2007

Chi-Med locks-in property gain and protects low cost R&D structure through acquisition of Shanghai facility

1 items
a070618